![Jakob W. Gotfredsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jakob W. Gotfredsen
No más puestos en curso
Historial de carrera de Jakob W. Gotfredsen
Antiguos cargos conocidos de Jakob W. Gotfredsen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Neurokey A/S
![]() Neurokey A/S Pharmaceuticals: MajorHealth Technology Neurokey wants to become a leading drug development company in the critical care field. The drugs under development will one day help countless patients suffering from the effects of debilitating and potentially fatal cardiovascular and neurological; diseases. Neurokey will be first to market with reliable efficient and easily administered medication that will increase the survival rate for these patients and dramatically minimize the risk of permanent neurological damage. | Fundador | 15/04/2010 | 30/07/2010 |
Corporate Officer/Principal | 07/07/2009 | 30/07/2010 | |
Presidente | 01/01/2007 | 07/07/2009 | |
Roche Pharmaceuticals, Inc.
![]() Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01/01/2005 | 01/01/2005 |
Formación de Jakob W. Gotfredsen.
University of Copenhagen | Masters Business Admin |
Estadísticas
Internacional
Dinamarca | 3 |
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 2 |
Founder | 1 |
President | 1 |
Sectorial
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Neurokey A/S
![]() Neurokey A/S Pharmaceuticals: MajorHealth Technology Neurokey wants to become a leading drug development company in the critical care field. The drugs under development will one day help countless patients suffering from the effects of debilitating and potentially fatal cardiovascular and neurological; diseases. Neurokey will be first to market with reliable efficient and easily administered medication that will increase the survival rate for these patients and dramatically minimize the risk of permanent neurological damage. | Health Technology |
Roche Pharmaceuticals, Inc.
![]() Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
- Bolsa de valores
- Insiders
- Jakob W. Gotfredsen
- Experiencia